Literature DB >> 3122247

Cocaine-calcium channel antagonist interactions.

M C Rowbotham1, W D Hooker, J Mendelson, R T Jones.   

Abstract

Diltiazem, a benzothiazepine calcium channel antagonist, was given to six healthy men as a single 60 mg oral dose 120 min before IV injection of cocaine (0.2 mg/kg) in a double-blind, placebo-controlled, two-session study. Diltiazem alone produced no significant effects. Cocaine increased blood pressure, heart rate, pupil size and subjective "high" ratings, and decreased skin temperature. Diltiazem pretreatment diminished the cocaine effect on skin temperature, but did not otherwise alter the response to cocaine. Calcium channel antagonists diminish the effects of cocaine in vitro and in animals. Dosage considerations may be critical because of the differential sensitivity of various tissues to calcium channel antagonists.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122247     DOI: 10.1007/bf00179925

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

Review 1.  Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.

Authors:  S H Snyder; I J Reynolds
Journal:  N Engl J Med       Date:  1985-10-17       Impact factor: 91.245

2.  A calcium-channel blocker as antidote to the cardiac effects of cocaine intoxication.

Authors:  G Nahas; R Trouvé; J R Demus; M von Sitbon
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

3.  The importance of calcium in amphetamine-induced turning behavior in mice with unilateral nigro-striatal lesions.

Authors:  Y K Fung; N J Uretsky
Journal:  Neuropharmacology       Date:  1980-06       Impact factor: 5.250

4.  Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries.

Authors:  G S Allen; S B Banghart
Journal:  Neurosurgery       Date:  1979-01       Impact factor: 4.654

5.  Cerebral arterial spasm: part 10. Reversal of acute and chronic spasm in dogs with orally administered nifedipine.

Authors:  G S Allen; A L Bahr
Journal:  Neurosurgery       Date:  1979-01       Impact factor: 4.654

6.  Presynaptic alpha 2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices.

Authors:  A M Galzin; S Z Langer
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

7.  Investigation of the role of calcium in the supersensitivity produced by cocaine in cat spleen strips.

Authors:  R J Summers; J Tillman
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

8.  Effects of verapamil, dantrolene and lanthanum on catecholamine release from rat adrenal medulla.

Authors:  J Cohen; Y Gutman
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

9.  Effects of reduced calcium ion concentration and of diltiazem on vasoconstrictor responses to noradrenaline and sympathetic nerve stimulation in rat isolated tail artery.

Authors:  I C Medgett; M A Rajanayagam
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

10.  Selective action of diltiazem on cerebral vascular smooth muscle in the rabbit: antagonism of extrinsic but not intrinsic maintained tone.

Authors:  J A Bevan
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

  10 in total
  4 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Neurologic aspects of cocaine abuse.

Authors:  M C Rowbotham
Journal:  West J Med       Date:  1988-10

3.  Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.

Authors:  D Kenny; P S Pagel; D C Warltier
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

4.  Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans.

Authors:  C Muntaner; K M Kumor; C Nagoshi; J H Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.